These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 14383148)
1. [New fields for using heparin]. SIMON K Med Klin; 1955 Mar; 50(13):535-7. PubMed ID: 14383148 [No Abstract] [Full Text] [Related]
2. Heparin in the treatment of acute stroke. Korczyn AD Neurol Clin; 1992 Feb; 10(1):209-17. PubMed ID: 1557003 [TBL] [Abstract][Full Text] [Related]
3. [The physiopathology of heparin; variations in the cholesterol/heparin quotient during heparin therapy]. PESCADOR L; OUTEIRINO J; SAINZ V Rev Clin Esp; 1955 Jan; 56(2):94-6. PubMed ID: 14385222 [No Abstract] [Full Text] [Related]
4. [Progress and new trends in the therapeutic use of heparin]. Neri Serneri GG; Gensini GF; Fortini A G Ital Cardiol; 1985 Jan; 15(1):98-106. PubMed ID: 3891489 [No Abstract] [Full Text] [Related]
6. [Mechanism of action and use of a new heparin body]. KAUTZSCH E Dtsch Med Wochenschr; 1956 Nov; 81(46):1846-50. PubMed ID: 13384124 [No Abstract] [Full Text] [Related]
7. On the value of the activated partial thrombo-plastin time (aptt) in monitoring heparin therapy. Teien AN; Abildgaard U Thromb Haemost; 1976 Jun; 35(3):592-7. PubMed ID: 989966 [TBL] [Abstract][Full Text] [Related]
8. [Clinical aspects of heparin induced thrombocytopenia]. Udvardy M; Boda Z; Rák K Orv Hetil; 1999 Jul; 140(30):1667-71. PubMed ID: 10461446 [TBL] [Abstract][Full Text] [Related]
9. [Heparin anticoagulant activity: new knowledge and future prospects]. Camici M; Giusti C; Evangelisti L Recenti Prog Med; 1991 Apr; 82(4):209-18. PubMed ID: 1857840 [TBL] [Abstract][Full Text] [Related]
10. [From heparin to heparins: toward new therapeutic perspectives?]. Molho P; Tobelem G Biomed Pharmacother; 1987; 41(4):171-5. PubMed ID: 3620582 [TBL] [Abstract][Full Text] [Related]
12. Monitoring heparin therapy using activated partial thromboplastin time--results of a multicenter trial establishing the therapeutic range for SILIMAT, a reagent with high sensitivity to heparin. Toulon P; Boutière B; Horellou MH; Trzeciak MC; Samama MM Thromb Haemost; 1998 Jul; 80(1):104-8. PubMed ID: 9684794 [TBL] [Abstract][Full Text] [Related]
13. [Heparin and psoriasis]. CROSTI A Minerva Dermatol; 1953 Dec; 28(12):316. PubMed ID: 13144458 [No Abstract] [Full Text] [Related]
15. [Use of heparin in cases of septic abortion (author's transl)]. Wille P Zentralbl Gynakol; 1980; 102(5):298-302. PubMed ID: 7211036 [TBL] [Abstract][Full Text] [Related]
16. [Monitoring of heparin therapy]. Camici M; Evangelisti L Minerva Med; 1993 Oct; 84(10):507-9. PubMed ID: 8247304 [TBL] [Abstract][Full Text] [Related]
17. [Therapy of angina pectoris with heparin]. FERRERO C Cardiologia (Basel); 1953; 23(2-3):102-5. PubMed ID: 13106864 [No Abstract] [Full Text] [Related]
18. [Treatment of labyrinthine vertigo by acetazolamide; comparative trials with chlorpromazine & heparin]. TARLE Y Ann Otolaryngol; 1957 Dec; 74(12):986-92. PubMed ID: 13509407 [No Abstract] [Full Text] [Related]
19. Heparin in the treatment of macular lesions. ROME S Trans Pac Coast Otoophthalmol Soc Annu Meet; 1958; 39():203-25; discussion 226-9. PubMed ID: 13635797 [No Abstract] [Full Text] [Related]
20. [Preliminary note on the treatment of stomach ulcer with heparin]. CATTAN R; FRUMUSAN P Arch Mal Appar Dig Mal Nutr; 1953 Nov; 42(11):1288-9. PubMed ID: 13139760 [No Abstract] [Full Text] [Related] [Next] [New Search]